Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Volume 51, Issue 6, Pages (December 2009)

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Immigration and viral hepatitis

Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results.

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

Clinical Approach to the Patient With Abnormal Liver Test Results

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

The place of downstaging for hepatocellular carcinoma

Liver Failure Secondary to Amyloid Light-Chain Amyloidosis

Juice Plus or Toxicity Plus

Autoimmune hepatitis: A life-long disease

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Herbs and Liver Injury: A Clinical Perspective

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Acute hepatitis C: Current status and remaining challenges

Darius Moradpour, Arash Grakoui, Michael P. Manns

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

EASL Clinical Practice Guidelines: Wilson’s disease

Unusual Aspects of Acute Q Fever-Associated Hepatitis

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Volume 69, Issue 6, Pages (December 2018)

Volume 57, Issue 5, Pages (November 2012)

Volume 50, Issue 4, Pages (April 2009)

Volume 70, Issue 3, Pages (March 2019)

Non-invasive diagnosis and biomarkers in alcohol-related liver disease

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Paul C. Adams, James C. Barton Journal of Hepatology

Volume 50, Issue 3, Pages (March 2009)

Immigration and viral hepatitis

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

Global burden of alcoholic liver diseases

Volume 64, Issue 6, Pages (June 2016)

The impact of intestinal microflora on serum bilirubin levels

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection Isabelle Chemin,

Table of contents The Journal for Nurse Practitioners

Cyclophosphamide-Induced Hepatitis in Wegener's Granulomatosis

The use of hemospray in portal hypertensive bleeding; a case series

Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice Paolo Angeli, Pere Gines

Volume 62, Issue 3, Pages (March 2015)

Volume 66, Issue 4, Pages (April 2017)

Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials? Jingzhi Cai, Wengang Guo, Chuangye.

Volume 46, Issue 3, Pages (March 2007)

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Volume 50, Issue 1, Pages 4-6 (January 2009)

Genetics of hepatocellular carcinoma: The next generation

MELD: the holy grail of organ allocation?

LINDA S. SNYDER, M.D., RUSSELL I. HEIGH, M.D., MONTE L. ANDERSON, M.D.

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Presentation transcript:

Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child Lupe Orostegui Journal of Hepatology Volume 58, Issue 1, Pages 195-198 (January 2013) DOI: 10.1016/j.jhep.2012.09.015 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Time profile of liver function tests after introduction and withdrawal of fondaparinux. AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, gamma glutamyltranspeptidase. Journal of Hepatology 2013 58, 195-198DOI: (10.1016/j.jhep.2012.09.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions